PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Diabetes trials worldwide are not addressing key issues in affected populations

With only 1 in 10 studying prevention while almost two-thirds focus on drug therapy

2013-04-06
(Press-News.org) An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies. The research is published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr Jennifer Green, Duke University Medical Center, Durham, NC, USA, and colleagues.

There are an estimated 371 million people with diabetes in the world. By 2030, there will be some 550 million with diabetes based on current trends. As such, research addressing the whole spectrum of diabetes care and treatment is essential. To examine whether current studies adequately address these needs, Green and colleagues analysed diabetes-related trials registered with ClinicalTrials.gov from 2007. The researchers found 2,484 interventional trials by selecting those with disease condition terms relevant to diabetes. Of these, 75% had a primarily therapeutic purpose while just 10% were preventive. Listed interventions were mostly drugs (63%) while few were behavioural (12%). Most of the studies were also small to medium sized, and were designed to enrol 500 or fewer participants (91%) or 100 or fewer (59%) participants, with mean/median times to completion of 1.8/1.4 years.

A very small proportion of trials targeted persons aged 18 years and under (4%). This may be appropriate given the number of children currently affected by diabetes; however, the estimated 3% annual increase in incidence of type 1 diabetes may warrant greater representation. Furthermore, the increase in type 2 diabetes among adolescents, particularly noticeable in wealthier nations, is of considerable concern, since as Dr Green notes "it is unclear whether findings obtained from trials of adults with diabetes are readily translatable to paediatric/adolescent populations". And despite the fact that nearly 20% of adults worldwide aged 65 years and over have diabetes, less than 1% of trials specifically targeted this age group, while 31% actually excluded patients over 65 years and almost all excluded those over 75 years.

"Only a tiny proportion of the trials analysed—1.4%—listed primary outcomes including mortality or clinically significant cardiovascular complications," says Dr Green. "Furthermore, distribution of registered trials by country does not reliably correlate with diabetes prevalence."

The International Diabetes Federation list of the 10 locations most affected by diabetes includes six Middle Eastern countries in which diabetes prevalence among adults is approximately 20% (Kuwait, Lebanon, Qatar, Saudi Arabia, Bahrain and the United Arab Emirates). However, this analysis by Green and colleagues, suggests that this region is minimally involved in the registered diabetes-related trials. Comparison of trial activities in countries with the highest diabetes prevalence among adults revealed 1126 trials in the USA. China, India and Mexico participated in 101 trials each; however, the Russian Federation (12.6 million persons with diabetes) and Brazil (12.4 million) are involved in fewer than 100 registered trials despite these heavy disease burdens.

Dr Green also says: "Rates of complications including diabetic retinopathy, lower extremity amputation, and end-stage renal disease vary among ethnic groups. To achieve the greatest impact upon clinical care, trials should enrol patients representative of populations disproportionately affected by diabetes and its complications. A better understanding of responses to interventions among diverse individuals and groups may inform individualised treatments of greater effectiveness and tolerability."

She concludes: "The majority of diabetes-related trials include small numbers of participants, exclude those at extremes of age, are of short duration, involve drug therapy rather than preventive or non-drug interventions, and do not focus upon significant cardiovascular outcomes. Recently registered diabetes trials may not sufficiently address important diabetes care issues or involve affected populations...Although many trials will provide valuable information upon completion, our review suggests that the current portfolio does not adequately address disease prevention, management, or therapeutic safety. This information may be meaningful in the allocation of future research activities and resources."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Huge disparities in hypertension seen across US counties

2013-04-06
SEATTLE – One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington revealed significant differences across the US. The study found the largest burden of hypertension in the southeast, the lowest prevalence in Colorado, and differences among genders, ethnic groups and geographies. But despite high prevalence ...

Electron conflict leads to 'bad traffic' on way to superconductivity

2013-04-06
HOUSTON -- (April 5, 2013) -- Rice University physicists on the hunt for the origins of high-temperature superconductivity have published new findings this week about a seemingly contradictory state in which a material simultaneously exhibits the conflicting characteristics of both a metallic conductor and an insulator. In a theoretical analysis this week in Physical Review Letters (PRL), Rice physicists Qimiao Si and Rong Yu offer an explanation for a strange series of observations described earlier this year by researchers at the Stanford Linear Accelerator ...

Stem cells enable personalized treatment for bleeding disorder

2013-04-06
Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients. The technique may enable doctors to prescribe more effective treatments according to the defects identified in patients' cells. In future, this approach could go much further: these same cells could be grown, manipulated, and applied as treatments for diseases of the heart, blood and circulation, including heart attacks and haemophilia. The study focused on von Willebrand disease (vWD), which ...

Liver transplantation for patients with genetic liver conditions has high survival rate

2013-04-06
Chicago (April 5, 2013): Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases. Among the main considerations are the anxiety of waiting for a donor organ, the risks associated with the transplant operation, and the chance that the transplant procedure will not achieve the desired result. There is also the six-figure cost of the procedure and accompanying patient care, all of which may not be completely covered by health ...

SFU researchers help unlock pine beetle's Pandora's box

2013-04-06
Twenty researchers — more than half of them Simon Fraser University graduates and/or faculty — could become eastern Canada's knights in shining white lab coats. A paper detailing their newly created sequencing of the mountain pine beetle's (MPB) genome will be gold in the hands of scientists trying to stem the beetle's invasion into eastern forests. The journal Genome Biology has published the paper. "We know a lot about how beetle infestations can devastate forests, just as the mountain pine beetle has been doing to B.C.'s lodgepole pines," says Christopher Keeling, ...

Experts call for research on prevalence of delayed neurological dysfunction after head injury

2013-04-06
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury (TBI). Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI. About one percent of the population in the developed world has experienced TBI, which can cause serious long-term ...

UT Arlington motor skills research nets good news for middle-aged

2013-04-06
People in their 20s don't have much on their middle-aged counterparts when it comes to some fine motor movements, researchers from UT Arlington have found. In a simple finger-tapping exercise, study participants' speed declined only slightly with age until a marked drop in ability with participants in their mid-60s. Priscila Caçola, an assistant professor of kinesiology at The University of Texas at Arlington, hopes the new work will help clinicians identify abnormal loss of function in their patients. Though motor ability in older adults has been studied widely, not ...

Corporate accounting earnings data relevant for determining value of the aggregate stock market

2013-04-06
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS - While teaching a course on financial information analysis, Asst. Prof. Panos Patatoukas observed that capital market participants and policy makers are increasingly turning to accounting earnings data from corporate financial reports for hints regarding the prospects of the aggregate stock market. This observation indicated that, at the aggregate level, accounting earnings data could be relevant for gauging the value of the entire stock market. Patatoukas, Haas Accounting Group, became so intrigued that he ...

Researcher offers clues on the origins of life

2013-04-06
TALLAHASSEE, Fla. — A structural biologist at the Florida State University College of Medicine has made discoveries that could lead scientists a step closer to understanding how life first emerged on Earth billions of years ago. Professor Michael Blaber and his team produced data supporting the idea that 10 amino acids believed to exist on Earth around 4 billion years ago were capable of forming foldable proteins in a high-salt (halophile) environment. Such proteins would have been capable of providing metabolic activity for the first living organisms to emerge on the ...

Vaccine adjuvant uses host DNA to boost pathogen recognition

2013-04-06
Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective. No one knows, however, how they boost the immune response. In the March 19, 2013, issue of the Proceedings of the National Academy of Sciences researchers at National Jewish Health continue unraveling the mystery of adjuvants with a report that host DNA coats the alum adjuvant and induces two crucial cells to interact twice as long during the initial stimulation of the adaptive immune system. "Alum makes T cells take a longer look at the antigen, which produces ...

LAST 30 PRESS RELEASES:

Employees who spot problems help the bottom line, so why do leaders give more power to bootlickers?

Could living near water mean you’ll live longer?

Alcohol withdrawal syndrome linked to worse surgical outcomes, higher costs

US POINTER trial: Structured lifestyle intervention delays cognitive decline

Detecting a potential behavioral biomarker for Parkinson’s disease in mice

Expectations about pain influence the experience in different ways

Landmark sleep study links objective sleep patterns with 172 diseases—regularity matters more than duration

Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment

CD4+ T cell-mediated immune drift in biologic treatment of inflammatory skin diseases

Spotlight on technology to protect older Australians from respiratory infections

There’s something in the air

New insights could help phages defeat antibiotic resistant bacteria

New system dramatically speeds the search for polymer materials

Safety of JN.1-updated mRNA COVID-19 vaccines

Type 2 diabetes and financial outcomes

A financial toll on patients with type 2 diabetes

Safflower yellow pigments in coronary heart disease: Mechanisms, applications, and future perspectives

TraMA: new RNA-based measure predicts mortality risk and tracks aging

From WebMD to AI chatbots: How innovation has empowered patients to take control of their health

Unravelling antileishmanial mechanisms of phytochemicals: From mitochondrial disruption to immunomodulation

Association for Molecular Pathology announces 2025 award recipients

When light collides with light

Study finds that white students visit college advisers the least, but benefit most in terms of graduation rates and GPA

Science by the millions: How everyday people are revolutionizing global biodiversity research with tech

A bolt is born! Atmospheric events underpinning lightning strikes explained

Using alcohol to reduce the costs of industrial water electrolysis

FAU researchers advise: prescribe high potency statins in treatment, prevention

15 regions chosen for groundbreaking effort to reduce cardiovascular disease

CareQuest Institute for Oral Health to fund year six of the AADOCR Mind the Future Program

Chungnam National University researchers reveal how vitamin D is shown to reduce liver damage by boosting TXNIP activity in cholangiocytes

[Press-News.org] Diabetes trials worldwide are not addressing key issues in affected populations
With only 1 in 10 studying prevention while almost two-thirds focus on drug therapy